Johnson & Johnson to acquire Shockwave Medical in $13.1bn deal
The acquisition of Shockwave Medical, which has developed the IVL technology, a minimally invasive, catheter-based treatment for calcified…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Apr 24
The acquisition of Shockwave Medical, which has developed the IVL technology, a minimally invasive, catheter-based treatment for calcified…
03 Apr 24
The FDA approval is based on results from TRILUMINATE trial, which showed that patients treated with TriClip system…
28 Mar 24
The Evolut FX+ TAVR system is designed to maintain the valve performance benefits of the legacy Evolut TAVR…
22 Mar 24
The DynamX BTK System is intended for the treatment of BTK vessels impacted by CLTI by widening the…
12 Mar 24
The iVAC 2L System has been designed to facilitate high-risk percutaneous coronary interventions by matching the natural rhythm…
11 Mar 24
CellFX percutaneous electrode system is intended for use in the ablation of soft tissue in percutaneous and intraoperative…
20 Feb 24
Comprising five universities, three clinical partners and an Australian-grown firm, the consortium intends to develop three next-generation implantable…
19 Feb 24
The Aurora EV-ICD system is manufactured by Medtronic and was approved for use by the Food and Drug…
15 Feb 24
Stethophone is an advanced software as a medical device (SaMD) that turns smartphones into medical-grade stethoscopes, and allows…
15 Feb 24
Continued Progress Earns Financing to Accelerate Commercial Growth and Advancing Pipeline